Atenor Valuation
Is 0NG6 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0NG6 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0NG6 (€4.05) is trading below our estimate of fair value (€19.05)
Significantly Below Fair Value: 0NG6 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0NG6?
Key metric: As 0NG6 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0NG6's PS Ratio? | |
|---|---|
| PS Ratio | 0.9x |
| Sales | €205.30m |
| Market Cap | €175.88m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 4.6x |
| Enterprise Value/EBITDA | 144.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0NG6's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 5.5x | ||
PSDL Phoenix Spree Deutschland | 6.8x | -13.0% | UK£158.9m |
ASLI abrdn European Logistics Income | 7.2x | n/a | UK£238.2m |
PCA Palace Capital | 4.1x | n/a | UK£64.1m |
PNS Panther Securities | 3.7x | n/a | UK£55.8m |
0NG6 Atenor | 0.9x | -3.5% | €175.9m |
Price-To-Sales vs Peers: 0NG6 is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (5.5x).
Price to Sales Ratio vs Industry
How does 0NG6's PS Ratio compare vs other companies in the GB Real Estate Industry?
Price-To-Sales vs Industry: 0NG6 is good value based on its Price-To-Sales Ratio (0.9x) compared to the UK Real Estate industry average (4.2x).
Price to Sales Ratio vs Fair Ratio
What is 0NG6's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.9x |
| Fair PS Ratio | 1.2x |
Price-To-Sales vs Fair Ratio: 0NG6 is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €4.05 | €6.05 +49.4% | 2.5% | €6.20 | €5.90 | n/a | 2 |
| Nov ’25 | €4.36 | €6.50 +49.3% | 4.6% | €6.80 | €6.20 | n/a | 2 |
| Oct ’25 | €5.10 | €6.50 +27.5% | 4.6% | €6.80 | €6.20 | n/a | 2 |
| Sep ’25 | €5.47 | €11.00 +101.1% | 57.9% | €20.00 | €6.20 | n/a | 3 |
| Aug ’25 | €5.80 | €13.40 +131.0% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| Jul ’25 | n/a | €13.40 0% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| Jun ’25 | €6.22 | €13.40 +115.4% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| May ’25 | €6.06 | €13.40 +121.1% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| Apr ’25 | €6.54 | €13.40 +104.9% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| Mar ’25 | €6.50 | €13.40 +106.1% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| Feb ’25 | €6.60 | €13.40 +103.0% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| Jan ’25 | €7.44 | €13.40 +80.1% | 49.3% | €20.00 | €6.80 | n/a | 2 |
| Nov ’24 | €13.65 | €24.67 +80.7% | 32.7% | €36.00 | €18.00 | €4.36 | 3 |
| Oct ’24 | €12.00 | €24.67 +105.6% | 32.7% | €36.00 | €18.00 | €5.10 | 3 |
| Sep ’24 | €18.35 | €29.33 +59.9% | 23.2% | €36.00 | €20.00 | €5.47 | 3 |
| Aug ’24 | €28.10 | €49.00 +74.4% | 26.5% | €62.00 | €36.00 | €5.80 | 2 |
| Jul ’24 | €26.30 | €53.50 +103.4% | 15.9% | €62.00 | €45.00 | n/a | 2 |
| Jun ’24 | €24.00 | €53.50 +122.9% | 15.9% | €62.00 | €45.00 | €6.22 | 2 |
| Dec ’23 | €48.90 | €63.00 +28.8% | 1.6% | €64.00 | €62.00 | €5.48 | 2 |
| Nov ’23 | €42.20 | €63.00 +49.3% | 1.6% | €64.00 | €62.00 | €13.65 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
Aroundtown
€3.5b
Operates as a real estate company in Germany, the Netherlands, the United Kingdom, Belgium, and internationally.
0RUH
€3.10
7D
14.8%
1Y
43.5%
UBM Development
€127.8m
Focuses on the development, management, and sale of real estate properties in Germany, Austria, Poland, and internationally.
0GD5
€17.90
7D
0%
1Y
-10.9%
VIB Vermögen
€229.4m
A real estate holding company, develops, buys, holds, rents, and manages commercial real estate properties in Germany.
VIH1D
€9.92
7D
0%
1Y
n/a